Baxter reports good results for cell-tissue flu vaccine

07/24/2007 | Chicago Tribune (tiered subscription model)

Baxter International said a Phase I trial showed "strong antibody responses and good tolerability" for its reformulated seasonal flu vaccine made with cell tissues. The company is intent on building its vaccine business, including a vaccine against avian flu, and the cell-based process eliminates the need for chicken eggs and speeds the production process for vaccines.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ